newsfilter
← Latest News
PR Newswire·

Ecovyst Reports Second Quarter 2026 Results and Raises 2026 Outlook

ECVT
  • Ecovyst Inc. reported second quarter 2026 sales of $250.0 million, a 42% increase from $176.1 million in the prior year quarter.
  • Net income for the quarter was $10.7 million compared to $5.0 million in the year-ago period, with diluted earnings per share of $0.10.
  • Adjusted Net Income reached $23.4 million, up from $11.4 million in the second quarter of 2025.
  • Adjusted EBITDA grew 27% to $53.1 million, driven by higher sales volume, favorable pricing, & strong demand for regenerated & virgin sulfuric acid.
  • The company completed the strategic acquisition of the Calabrian sulfur dioxide business from INEOS Enterprises on June 30, 2026.
  • Cash flow from operating activities for the six months ended June 30, 2026, was $55.2 million, compared to $25.3 million in the prior year period.
  • Adjusted Free Cash Flow for the first six months was $12.8 million, reversing a negative $2.4 million from the same period in 2025.
  • Revised full-year 2026 guidance now projects Sales of $1,020 million to $1,060 million, reflecting the anticipated contribution from the Calabrian acquisition.
  • Full-year 2026 Adjusted EBITDA guidance was raised to a range of $195 million to $207 million, up from the previous range of $180 million to $195 million.
  • The company holds $87.8 million in cash & cash equivalents, with total available liquidity of $176.3 million including $88.5 million under the ABL facility.
  • Total gross debt stands at $497.1 million, resulting in a net debt leverage ratio of 2.0x as of June 30, 2026.
  • During the first six months of 2026, Ecovyst repurchased 3,226,461 shares for a total cost of $35.7 million, with $146.5 million remaining available under its stock repurchase program.
  • Sales growth was attributed to higher average selling prices due to sulfur cost pass-throughs & increased volume from the Waggaman plant & reduced customer downtime.
  • Management expects strong demand for regenerated acid in the second half of 2026 but anticipates lower spot sales for virgin sulfuric acid.